Literature DB >> 29527654

British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding.

Laura Green1,2,3, Paula Bolton-Maggs4, Craig Beattie5, Rebecca Cardigan6, Yiannis Kallis3,7, Simon J Stanworth8, Jecko Thachil9, Sharon Zahra10.   

Abstract

Entities:  

Keywords:  cryoprecipitate; fresh frozen plasma; guidelines; non-bleeding patients; plasma

Mesh：

Substances：

Year:  2018        PMID： 29527654     DOI： 10.1111/bjh.15167

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  23 in total

1.  Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB).

Authors:  Marianne E Nellis; Oliver Karam; Stacey L Valentine; Scot T Bateman; Kenneth E Remy; Jacques Lacroix; Jill M Cholette; Melania M Bembea; Robert T Russell; Marie E Steiner; Susan M Goobie; Marisa Tucci; Paul A Stricker; Simon J Stanworth; Meghan Delaney; Lani Lieberman; Jennifer A Muszynski; David F Bauer; Katherine Steffen; Daniel Nishijima; Juan Ibla; Sitaram Emani; Adam M Vogel; Thorsten Haas; Ruchika Goel; Gemma Crighton; Diana Delgado; Michelle Demetres; Robert I Parker
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.624

2.  Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.

Authors:  Lara N Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  The Alterations in Methylene Blue/Light-Treated Frozen Plasma Proteins Revealed by Proteomics.

Authors:  Tiange Wu; Xiaoning Wang; Kai Ren; Xiaochen Huang; Jiankai Liu
Journal:  Transfus Med Hemother       Date:  2021-03-23       Impact factor: 3.747

4.  A retrospective audit to evaluate the appropriateness and rationalization of Fresh Frozen Plasma usage in a tertiary care hospital.

Authors:  Sudeep Kumar; Neerja Kushwaha; Akshaya Tomar; Joseph Philip; Amit Kumar Biswas
Journal:  Med J Armed Forces India       Date:  2021-07-30

5.  Common haemostasis issues in major bleeding and critical illness.

Authors:  Divyansh Gulati; Alex Novak; Simon J Stanworth
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

6.  Consensus Report on Patient Blood Management in Cardiac Surgery by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Cardiology (TSC), and Society of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care (SCTAIC).

Authors:  Serkan Ertugay; Türkan Kudsioğlu; Taner Şen
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

7.  The impact of organisational change on transfusion practices in perioperative care: an analysis of blood product use following the merger of three London cardiac surgery units to form the Barts Heart Centre.

Authors:  Sibtain Anwar; Laura Green; Jackie Cooper; Miles Curtis; Neil Roberts; Julie Sanders; Marie Scully; Victoria Stables; Ben O'Brien
Journal:  Future Healthc J       Date:  2020-02

8.  Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate.

Authors:  Michael Wallisch; Sven R Olson; Jeffrey Crosby; Jennifer Johnson; Susan F Murray; Joseph J Shatzel; Erik I Tucker; Owen J T McCarty; Monica T Hinds; Brett P Monia; András Gruber
Journal:  Cell Mol Bioeng       Date:  2020-03-23       Impact factor: 2.321

9.  Anaesthetic implications and transfusion practices in ABO incompatible living donor liver transplantation: Case series.

Authors:  Sindhu Balakrishnan; Lakshmi Kumar; Divya Daniel; Sudhindran Surendran
Journal:  Indian J Anaesth       Date:  2021-04-15

10.  Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature.

Authors:  Elisabeth Hannah Adam; Dania Fischer
Journal:  Transfus Med Hemother       Date:  2020-09-18       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.